Size exclusion chromatography (SEC) is fast becoming the purification method of choice for extracellular vesicles including exosomes. However, the technique has been confined to relatively low throughput, single-column formats. Continued improvementsas led to a new high-throughput isolation product that has overcome this limitation.
Cell-based assays are a cornerstone of research and drug development. However, the beneficial effects of promising drugs can easily be missed amidst the noise of experimental data. This means good drug candidates are often overlooked. Just as concerning, data that would otherwise flag problematic candidates can be missed allowing drug candidates to progress to later stages before eventually failing.
Three-dimensional (3D) culture systems are becoming increasingly popular in both biomedical research and in drug discovery. It is becoming widely accepted that in vitro 3D cell culture technologies have the ability to mimic tissue-like structures and both physiological and disease states more effectively than traditional two-dimensional (2D) monolayer cultures on plastic surfaces.
Despite recent remarkable advances in the treatment of some cancers, pancreatic cancer patients still have one of the worst survival rates. Pancreatic ductal adenocarcinoma’s (PDAC) five-year survival is only 2%-9%. This poor prognosis can largely be attributed to two major factors. Firstly, owing to relatively benign presenting features, the disease is not diagnosed until it has progressed to advanced or metastatic stages in >70% of patients.